Related Experiment Video
Updated: Jul 21, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Influence of Pneumococcal Conjugate Vaccine on Acute Otitis Media with Severe Middle Ear Inflammation: A
Hirotoshi Sugino1, Shigeru Tsumura2, Masaru Kunimoto3
1Asa Medical Association, Hiroshima City, Japan; Sugino Pediatric Clinic, Hiroshima City, Japan.
Insights
The heptavalent pneumococcal conjugate vaccine significantly reduced myringotomy rates for acute otitis media in young children in Hiroshima. This suggests the vaccine lessens the need for surgical intervention and associated healthcare costs.
Area of Science:
- Pediatrics
- Infectious Diseases
- Otolaryngology
Background:
- Japanese guidelines recommend myringotomy for severe acute otitis media (AOM) in children.
- The heptavalent pneumococcal conjugate vaccine (PCV7) became publicly funded in Hiroshima in January 2011.
- AOM is a common childhood infection often requiring medical or surgical intervention.
Purpose of the Study:
- To evaluate the impact of PCV7 public funding on the incidence of myringotomy procedures for AOM.
- To assess changes in myringotomy rates in children under 5 and specifically in 1-year-old infants.
Main Methods:
- Retrospective analysis of myringotomy procedures for AOM performed between January 2008 and December 2012.
- Data collected from two hospitals and five clinics in the Asa Area of Hiroshima City, Japan.
- Comparison of procedure rates before and after the introduction of public funding for PCV7.
Main Results:
- A total of 3,165 myringotomies for AOM were performed during the study period.
- Myringotomy rates in children under 5 decreased by 29.1% in 2011 and 25.2% in 2012 compared to pre-funding years.
- Myringotomy rates in 1-year-old infants significantly decreased post-PCV7 funding introduction (p<0.000001).
Conclusions:
- PCV7 public funding is associated with a substantial reduction in myringotomy procedures for AOM.
- The vaccine may decrease the financial burden associated with AOM treatment.
- PCV7 may play a role in preventing severe middle ear inflammation in infants.
Abstract:
The Japanese guidelines for acute otitis media in children recommend classifying acute otitis media by age, manifestations and local findings, and also recommend myringotomy for moderate-grade cases with severe local findings, severe-grade cases, and treatment-resistant cases. The heptavalent pneumococcal conjugate vaccine was released in Japan in February 2010. In Hiroshima City, public funding allowing free inoculation with this vaccine was initiated from January 2011, and the number of vaccinated individuals has since increased dramatically. This study investigated changes in the number of myringotomies performed to treat acute otitis media during the 5-year period from January 2008 to December 2012 at two hospitals and five clinics in the Asa Area of Hiroshima City, Japan. A total of 3,165 myringotomies for acute otitis media were performed. The rate of procedures per child-year performed in <5-year-old children decreased by 29.1% in 2011 and by 25.2% in 2012 compared to the mean rate performed in the 3 years prior to the introduction of public funding. A total of 895 myringotomies were performed for 1-year-old infants. The rate of myringotomies per child-year performed for acute otitis media in 1-year-old infants decreased significantly in the 2 years after the introduction of public funding for heptavalent pneumococcal conjugate vaccine compared to all years before introduction (p<0.000001). Our results suggest a benefit of heptavalent pneumococcal conjugate vaccine for acute otitis media in reducing the financial burden of myringotomy. In addition, this vaccine may help prevent acute otitis media with severe middle ear inflammation in 1-year-old infants.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Bacterial Meningitis
Streptococcal Pharyngitis
Pneumonia I: Introduction